Five new amicoumacins isolated from a marine-derived bacterium Bacillus subtilis

Area of Science:

• Marine microbiology
• Natural product chemistry
• Bacterial secondary metabolites

Background:

• Bacillus subtilis is a well-known bacterium with diverse metabolic capabilities.
• Marine microorganisms are a rich source of novel bioactive compounds.
• Amicoumacins are a class of natural products with potential biological activities.

Purpose of the Study:

• To isolate and characterize novel compounds from a marine-derived Bacillus subtilis.
• To expand the known chemical diversity of amicoumacins and related structures.
• To investigate the secondary metabolite profile of marine Bacillus subtilis.

Main Methods:

• Cultivation of marine-derived Bacillus subtilis.
• Extraction and isolation of compounds from culture broth.
• Structure elucidation using extensive spectroscopic analyses including 2D NMR, IR, CD, and MS.
• Comparison with existing literature data for known compounds.

Main Results:

• Isolation of four novel lipoamicoumacins (1-4).
• Isolation of one new bacilosarcin analog (5).
• Identification of six known amicoumacins.
• Complete structural elucidation of all isolated compounds.

Conclusions:

• Marine-derived Bacillus subtilis produces a diverse range of amicoumacin-related compounds.
• The study expands the known chemical structures within the amicoumacin family.
• This research highlights the potential of marine bacteria as a source for novel natural products.